Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jun;36(3):637-648.
doi: 10.1007/s10877-021-00689-x. Epub 2021 Mar 18.

In vitro validation and characterization of pulsed inhaled nitric oxide administration during early inspiration

Affiliations

In vitro validation and characterization of pulsed inhaled nitric oxide administration during early inspiration

Philipp A Pickerodt et al. J Clin Monit Comput. 2022 Jun.

Abstract

Purpose: Admixture of nitric oxide (NO) to the gas inspired with mechanical ventilation can be achieved through continuous, timed, or pulsed injection of NO into the inspiratory limb. The dose and timing of NO injection govern the inspired and intrapulmonary effect site concentrations achieved with different administration modes. Here we test the effectiveness and target reliability of a new mode injecting pulsed NO boluses exclusively during early inspiration.

Methods: An in vitro lung model was operated under various ventilator settings. Admixture of NO through injection into the inspiratory limb was timed either (i) selectively during early inspiration ("pulsed delivery"), or as customary, (ii) during inspiratory time or (iii) the entire respiratory cycle. Set NO target concentrations of 5-40 parts per million (ppm) were tested for agreement with the yield NO concentrations measured at various sites in the inspiratory limb, to assess the effectiveness of these NO administration modes.

Results: Pulsed delivery produced inspiratory NO concentrations comparable with those of customary modes of NO administration. At low (450 ml) and ultra-low (230 ml) tidal volumes, pulsed delivery yielded better agreement of the set target (up to 40 ppm) and inspiratory NO concentrations as compared to customary modes. Pulsed delivery with NO injection close to the artificial lung yielded higher intrapulmonary NO concentrations than with NO injection close to the ventilator. The maximum inspiratory NO concentration observed in the trachea (68 ± 30 ppm) occurred with pulsed delivery at a set target of 40 ppm.

Conclusion: Pulsed early inspiratory phase NO injection is as effective as continuous or non-selective admixture of NO to inspired gas and may confer improved target reliability, especially at low, lung protective tidal volumes.

Keywords: ARDS; Artificial lung; Inhalation; Mechanical ventilation; Nitric oxide; PiNO.

PubMed Disclaimer

Conflict of interest statement

Maria Deja has received a restricted grant from Linde® Gas Therapeutics, manufacturer and distributor of nitric oxide. Moritz Hofferberth has received salary in parts from this grant. Philipp Pickerodt has received one speaker fee from Linde® Gas Therapeutics. Rainer Köbrich is an employee of EKU Elektronik GmbH, the manufacturer of the NO Device used for this study. The authors declare that they have no further conflict of interests.

Figures

Fig. 1
Fig. 1
Schematic setup of the artificial lung model. Mechanical breaths from the ventilator inflate lung 1 (valve A), thereby raising a lifting bar to cause aspiration of ambient air into lung 2. Expiration into the breathing system occurs from lung 2 (valve B), while lung 1 releases to ambient air. Sites of NO injection and sampling and the distance from the ventilator or Y-piece are indicated along the breathing circuit. Injection: 20 cm distal from the ventilator, 10 cm proximal of Y-piece. Sampling: 40 and 120 cm distal from ventilator, 4 cm proximal of Y-piece, Y-piece, mid-tracheal, and artificial lung 1. Figure adapted and modified from [13]
Fig. 2
Fig. 2
a Inspiratory NO concentrations achieved with “pulsed delivery”. NO was injected as a bolus during early inspiration into the breathing circuit at 20 cm after the mechanical ventilator, sampled at 120 cm thereafter, and quantified with ozone-based chemiluminescence. Ultra-low (230 ml), low (450 ml) or traditional (750 ml) tidal volumes were applied via both pressure and volume-controlled ventilation with I:E ratios of 1:1 and 1:1.9 (4 conditions). Mean NO concentrations were determined for 120 s (n = 30 respiratory cycles) per each individual ventilation condition (i.e. n = 120 per bar representing 4 ventilation conditions). Means ± SD. *p < 0.05 vs. target. b Target reliability of NO administration modes. NO was administered via “pulsed”, “flow proportional” or “continuous delivery” through injection into the breathing circuit at 20 cm after the mechanical ventilator, sampled at 120 cm thereafter, and quantified with ozone-based chemiluminescence. For each NO target concentration, mechanical ventilation was performed with ultra-low (230 ml), low (450 ml) or traditional (750 ml) tidal volumes applied via both pressure and volume-controlled ventilation with I:E ratios of 1:1 and 1:1.9 (12 conditions). NO concentrations were determined for 120 s (n = 30 respiratory cycles) per each individual ventilation condition (i.e. n = 360 per data point representing 12 ventilation conditions; n = 354 for “flow proportional delivery” at 5 ppm). The level of agreement is depicted by the mean inspiratory NO concentration expressed as a percentage of the target value ± SD. *p < 0.05 between respective modes
Fig. 3
Fig. 3
Sensitivity of NO quantification methods. The graph depicts the theoretical temporal resolution of ozone-based chemiluminescence (OBC, blue) versus an electrochemical sensor (ECS, black) in retracing fluctuations of the true NO concentration (red)

References

    1. Higenbottam TW, Pepke-Zaba J, Woolman P, Wallwork J. Inhaled endothelium-derived relaxing factor (EDRF) in primary pulmonary hypertension (PPH) Am Rev Respir Dis. 1988;137:A107.
    1. Rossaint R, Falke KJ, Lopez F, Slama K, Pison U, Zapol WM. Inhaled nitric oxide for the adult respiratory distress syndrome. N Engl J Med. 1993;328:399–405. doi: 10.1056/NEJM199302113280605. - DOI - PubMed
    1. Creagh-Brown BC, Griffiths MJ, Evans TW. Bench-to-bedside review: inhaled nitric oxide therapy in adults. Crit Care. 2009;13:221. doi: 10.1186/cc7734. - DOI - PMC - PubMed
    1. Lewandowski K. Nitric oxide as an adjunct. In: Tobin MJ, editor. Principles and practice of mechanical ventilation. New York: McGraw Hill; 2013. pp. 1389–1403.
    1. Afshari A, Brok J, Moller AM, Wetterslev J. Inhaled nitric oxide for acute respiratory distress syndrome and acute lung injury in adults and children: a systematic review with meta-analysis and trial sequential analysis. Anesth Analg. 2011;211:1411–1421. doi: 10.1213/ANE.0b013e31820bd185. - DOI - PubMed

Publication types

LinkOut - more resources